This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2002
Title: The Innovative Contributions of Andrew Parsons
Introduction
Andrew Parsons is a notable inventor based in Arlesey, GB. He has made significant contributions to the field of medical science, particularly in the treatment of neurological disorders. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Parsons' latest patents include the use of benzopyranols to treat neurological disorders. This patent discloses benzopyran derivatives and analogs that are useful for the treatment and/or prophylaxis of conditions such as neuralgia, trigeminal neuralgia, neuropathic pain, dental pain, and cancer pain. Another significant patent involves the use of 5HT.sub.1B receptor antagonists for the treatment of vascular issues.
Career Highlights
Andrew Parsons is currently associated with SmithKline Beecham Corporation, where he continues to innovate and develop new treatments. His work is characterized by a commitment to improving patient outcomes through scientific research and development.
Collaborations
Throughout his career, Parsons has collaborated with esteemed colleagues, including Mervyn Thompson and Neil Upton. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
In summary, Andrew Parsons is a dedicated inventor whose work in the field of neurological treatment showcases his innovative spirit and commitment to advancing medical science. His contributions are paving the way for new therapeutic options that could benefit many patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile